November 04, 2025

Get In Touch

Increased HbA1c And HOMA-IR May Predict Risk Of Gestational Diabetes Early In Pregnancy

China: According to a study published in Diabetes Research and Clinical Practice, researchers have concluded that there is an increased incidence of gestational diabetes mellitus (GDM) with increasing HbA1c and HOMA-IR.
They also mentioned that gestational diabetes risk is higher when both HbA1c and HOMA-IR are higher. The study has addressed the need to identify high-risk women for gestational diabetes mellitus early in pregnancy so that timely interventions could be provided.

Researchers in the present study investigated the association of glycated haemoglobin (HbA1c) and homeostasis model assessment insulin resistance (HOMA-IR) with gestational diabetes mellitus (GDM) risk. They included pregnant women with HbA1c, fasting insulin, and fasting glucose (FG) measured at 15-20 weeks of gestation. These underwent oral glucose tolerance test (OGTT) at 24-28 weeks.
The study results explained as follows:
Researchers identified 462 women, out of which 29.44 % of women developed GDM.
Based on HbA1c and HOMA-IR, there were four groups in the study population, with the percentages of each group being 51.30%, 15.58%, 20.56%, and 12.55%, respectively.
With the increase in HOMA-IR and HbA1c, GDM incidence increased with the increase of HOMA-IR and HbA1c, respectively.
GDM risk increased when both HOMA-IR and HbA1c were elevated.
In pregnant women < 35 years, there was no risk.
Finally, we found significantly higher FG at 24-28 weeks in the high HOMA-IR and HbA1c group among GDM-positive pregnant women.
The study has highlighted that GDM incidence increases with increasing HOMA-IR and HbA1c, respectively carrying the highest risk when maternal HOMA- IR and HbA1c are elevated in pregnant women aged ≥ 35 years.
They said, based on the results of our study, we found that among pregnant women with GDM, fasting glucose is higher at 24-28 weeks in those with elevated IR and HbA1c, independent of age.
Further reading:
Combining HbA1c and insulin resistance to assess the risk of gestational diabetes mellitus: a prospective cohort study. https://doi.org/10.1016/j.diabres.2023.110673

Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our Terms of Use, Privacy Policy, and Advertisement Policy.
For further details, please review our Full Disclaimer.

0 Comments

Post a comment

Please login to post a comment.

No comments yet. Be the first to comment!